Private Advisor Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $58.7M | Sell |
233,214
-33,032
| -12% | -$7.11M | 0.27% | 70 |
|
|
2026
Q1 | $57.9M | Sell |
266,246
-17,848
| -6% | -$3.96M | 0.27% | 72 |
|
|
2025
Q4 | $64.9M | Buy |
284,094
+7,711
| +3% | +$1.76M | 0.31% | 60 |
|
|
2025
Q3 | $64M | Sell |
276,383
-3,553
| -1% | -$724K | 0.31% | 57 |
|
|
2025
Q2 | $52M | Buy |
279,936
+11,042
| +4% | +$2.05M | 0.28% | 72 |
|
|
2025
Q1 | $56.3M | Sell |
268,894
-208,443
| -44% | -$40.5M | 0.34% | 57 |
|
|
2024
Q4 | $84.8M | Buy |
477,337
+201,178
| +73% | +$37M | 0.48% | 33 |
|
|
2024
Q3 | $54.6M | Sell |
276,159
-4,392
| -2% | -$820K | 0.34% | 59 |
|
|
2024
Q2 | $48M | Buy |
280,551
+24,896
| +10% | +$4.12M | 0.32% | 62 |
|
|
2024
Q1 | $46.6M | Sell |
255,655
-5,649
| -2% | -$974K | 0.33% | 63 |
|
|
2023
Q4 | $40.5M | Sell |
261,304
-93
| -0% | -$13.6K | 0.31% | 68 |
|
|
2023
Q3 | $39M | Sell |
261,397
-6,623
| -2% | -$972K | 0.35% | 60 |
|
|
2023
Q2 | $37M | Sell |
268,020
-6,590
| -2% | -$966K | 0.32% | 66 |
|
|
2023
Q1 | $43.8M | Sell |
274,610
-21,720
| -7% | -$3.32M | 0.42% | 44 |
|
|
2022
Q4 | $10.1M | Sell |
296,330
-11,404
| -4% | -$1.75M | 0.51% | 37 |
|
|
2022
Q3 | $41.3M | Sell |
307,734
-81,871
| -21% | -$11.7M | 0.47% | 38 |
|
|
2022
Q2 | $59.7M | Sell |
389,605
-44,140
| -10% | -$6.74M | 0.53% | 34 |
|
|
2022
Q1 | $70.3M | Buy |
433,745
+30,356
| +8% | +$4.41M | 0.54% | 31 |
|
|
2021
Q4 | $54.6M | Sell |
403,389
-153,113
| -28% | -$18.1M | 0.41% | 44 |
|
|
2021
Q3 | $60M | Buy |
556,502
+162,314
| +41% | +$18.5M | 0.38% | 54 |
|
|
2021
Q2 | $44.4M | Buy |
394,188
+31,949
| +9% | +$3.6M | 0.39% | 46 |
|
|
2021
Q1 | $39.2M | Buy |
362,239
+80,606
| +29% | +$8.62M | 0.37% | 50 |
|
|
2020
Q4 | $30.2M | Buy |
281,633
+57,142
| +25% | +$5.49M | 0.31% | 62 |
|
|
2020
Q3 | $20M | Buy |
224,491
+321
| +0.1% | +$30.2K | 0.26% | 76 |
|
|
2020
Q2 | $22M | Buy |
224,170
+29,503
| +15% | +$2.6M | 0.31% | 65 |
|
|
2020
Q1 | $14.8M | Buy |
194,667
+15,369
| +9% | +$1.31M | 0.27% | 75 |
|
|
2019
Q4 | $15.9M | Buy |
179,298
+18,857
| +12% | +$1.57M | 0.25% | 89 |
|
|
2019
Q3 | $12.2M | Buy |
160,441
+29,856
| +23% | +$2.05M | 0.19% | 115 |
|
|
2019
Q2 | $9.5M | Sell |
130,585
-12,242
| -9% | -$962K | 0.17% | 133 |
|
|
2019
Q1 | $11.5M | Sell |
142,827
-3
| -0% | -$245 | 0.23% | 97 |
|
|
2018
Q4 | $13.2M | Sell |
142,830
-6,374
| -4% | -$561K | 0.32% | 66 |
|
|
2018
Q3 | $14.1M | Sell |
149,204
-12,446
| -8% | -$1.18M | 0.29% | 71 |
|
|
2018
Q2 | $15M | Buy |
161,650
+67,347
| +71% | +$6.58M | 0.25% | 29 |
|
|
2018
Q1 | $8.93M | Buy |
94,303
+2,417
| +3% | +$266K | 0.35% | 60 |
|
|
2017
Q4 | $9.12M | Sell |
91,886
-67,101
| -42% | -$6.32M | 0.39% | 55 |
|
|
2017
Q3 | $14.4M | Sell |
158,987
-4,609
| -3% | -$351K | 0.36% | 59 |
|
|
2017
Q2 | $11.8M | Buy |
163,596
+7,920
| +5% | +$532K | 0.32% | 71 |
|
|
2017
Q1 | $10.1M | Buy |
155,676
+15,804
| +11% | +$994K | 0.28% | 80 |
|
|
2016
Q4 | $8.56M | Buy |
139,872
+23,316
| +20% | +$1.42M | 0.28% | 84 |
|
|
2016
Q3 | $7.34M | Sell |
116,556
-18,606
| -14% | -$1.2M | 0.3% | 79 |
|
|
2016
Q2 | $8.56M | Buy |
135,162
+25,271
| +23% | +$1.54M | 0.35% | 65 |
|
|
2016
Q1 | $6.29M | Sell |
109,891
-858
| -0.8% | -$47.8K | 0.3% | 75 |
|
|
2015
Q4 | $6.56M | Buy |
110,749
+11,909
| +12% | +$686K | 0.31% | 73 |
|
|
2015
Q3 | $5.38M | Buy |
98,840
+9,704
| +11% | +$632K | 0.3% | 75 |
|
|
2015
Q2 | $5.98M | Buy |
89,136
+11,027
| +14% | +$720K | 0.28% | 68 |
|
|
2015
Q1 | $4.57M | Buy |
78,109
+8,827
| +13% | +$533K | 0.26% | 79 |
|
|
2014
Q4 | $4.47M | Buy |
69,282
+7,580
| +12% | +$478K | 0.29% | 79 |
|
|
2014
Q3 | $3.56M | Buy |
61,702
+9,935
| +19% | +$552K | 0.25% | 95 |
|
|
2014
Q2 | $2.92M | Buy |
51,767
+12,295
| +31% | +$645K | 0.25% | 88 |
|
|
2014
Q1 | $2.03M | Buy |
39,472
+3,098
| +9% | +$157K | 0.21% | 108 |
|
|
2013
Q4 | $1.92M | Buy |
+36,374
| New | +$1.79M | 0.21% | 103 |
|
Other funds holding ABBV
ECSS
ATO
Private Advisor Group's ABBV Position: Q2 2026 in Review
Private Advisor Group reduced its AbbVie (ABBV) stake by 12% in Q2 2026, selling an estimated $7.11M and leaving 233,214 shares worth $58.7M. The position accounts for 0.27% of the portfolio, ranked #70.
Private Advisor Group first reported a position in ABBV in Q4 2013 and has held it in 51 quarters since. The position peaked at $84.8M in Q4 2024. 1,885 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Private Advisor Group held 233,214 shares of AbbVie worth $58.7M as of Q2 2026.
- Private Advisor Group sold 33,032 AbbVie shares in Q2 2026, an estimated $7.11M.
- AbbVie made up 0.27% of Private Advisor Group's portfolio in Q2 2026, its #70 holding.
- Private Advisor Group first reported a position in AbbVie in Q4 2013 and has held it in 51 quarters since.
- Private Advisor Group's AbbVie position peaked at $84.8M in Q4 2024.
- 1,885 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.